Schwartz/Reisman Emergency Medicine Institute, Sinai Health, Toronto, Ontario, Canada.
Division of Emergency Medicine, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Acad Emerg Med. 2023 Sep;30(9):955-962. doi: 10.1111/acem.14671. Epub 2023 Feb 24.
Many patients are initially diagnosed with a new suspected cancer through the emergency department (ED). The objective of this systematic review was to compare stage of cancer and survival of patients diagnosed with cancer through the ED to patients diagnosed elsewhere.
Electronic searches of Medline and EMBASE were conducted and reference lists were hand-searched. Studies comparing adult patients diagnosed with any type of cancer through the ED (ED diagnosis) to patients diagnosed elsewhere (non-ED diagnosis) were included. Two reviewers independently screened titles and abstracts, assessed quality of the studies, and extracted data. The risk of bias of included studies was assessed using the Newcastle-Ottawa Scale. Data pertaining to patient outcomes were summarized and pooled using random-effects models and reported as risk ratios (RRs) with 95% confidence intervals (CIs), where applicable.
Fourteen studies were included. There was an increased risk of more advanced/later stage cancer (Stage III/IV or late-stage vs. earlier stage) among patients with an ED diagnosis of cancer compared to a non-ED diagnosis of cancer (RR 1.30, 95% CI 1.39-1.58). Survival was lower for patients with an ED diagnosis of cancer compared to those diagnosed elsewhere (RR 0.61, 95% CI 0.49-0.75).
Patients with an ED diagnosis of cancer had more advanced/late stage of cancer at diagnosis and worse survival compared to patients diagnosed elsewhere. Future research examining patients diagnosed with cancer through the ED is required.
许多患者最初是通过急诊科(ED)诊断出患有新的疑似癌症。本系统评价的目的是比较通过 ED 诊断出癌症的患者与在其他地方诊断出癌症的患者的癌症分期和生存情况。
对 Medline 和 EMBASE 进行电子检索,并手动检索参考文献列表。纳入比较通过 ED(ED 诊断)诊断为任何类型癌症的成年患者与在其他地方(非 ED 诊断)诊断为癌症的患者的研究。两名评审员独立筛选标题和摘要,评估研究质量,并提取数据。使用纽卡斯尔-渥太华量表评估纳入研究的偏倚风险。使用随机效应模型汇总和汇总与患者结局相关的数据,并以风险比(RR)和 95%置信区间(CI)报告,在适用的情况下。
纳入了 14 项研究。与非 ED 诊断癌症相比,ED 诊断癌症的患者癌症分期更晚/更晚期(III/IV 期或晚期与早期)的风险增加(RR 1.30,95%CI 1.39-1.58)。与在其他地方诊断出癌症的患者相比,ED 诊断癌症的患者的生存率较低(RR 0.61,95%CI 0.49-0.75)。
与在其他地方诊断出癌症的患者相比,ED 诊断癌症的患者在诊断时癌症分期更晚/更晚期,生存情况更差。需要进一步研究通过 ED 诊断出癌症的患者。